Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions
Remarks:
no E.coli WP2 or TA 102 was tested

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1988
Report date:
1988

Materials and methods

Test guidelineopen allclose all
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 472 (Genetic Toxicology: Escherichia coli, Reverse Mutation Assay)
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Perylene-3,4:9,10-tetracarboxylic dianhydride
EC Number:
204-905-3
EC Name:
Perylene-3,4:9,10-tetracarboxylic dianhydride
Cas Number:
128-69-8
Molecular formula:
C24H8O6
IUPAC Name:
7,18-dioxaheptacyclo[14.6.2.2²,⁵.0³,¹².0⁴,⁹.0¹³,²³.0²⁰,²⁴]hexacosa-1(23),2,4,9,11,13,15,20(24),21,25-decaene-6,8,17,19-tetrone
Details on test material:
Test materials used in this dossier are all considered to fall under the definition of nano-materials according to the European Commission Recommendation 2011/696/EU as the synthesis and manufacturing of this pigment always yields particulate material with a fine particle size distribution.
Specific details on test material used for the study:
- Name of test material (as cited in study report): persäure rein (english: peroxy acid, pure)
- Chemical nomenclature: Perylene-3,4,9,10-tetracarbonacid dianhydride
- Physical state: red powder
- Batch No.: EMHE 995

Method

Target gene:
his, trp
Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Species / strain / cell type:
S. typhimurium TA 1538
Metabolic activation:
with and without
Metabolic activation system:
metabolising system (induced with Aroclor 1254) derived from rat liver homogenate
Test concentrations with justification for top dose:
4, 20, 100, 500, 2500, 5000 µg/plate
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: see "details on test system"
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation)

DURATION: incubation for 48 to 72 hour at 37°C in the dark

NUMBER OF REPLICATIONS: 3

DETERMINATION OF CYTOTOXICITY
- Method: bacterial growth

The first experiment was performed with all tester strains using three plates per dose to get information on mutagenicity and toxicity for calculation of an appropriate dose range. A reduced rate of spontaneously occurring colonies as well as visible thinning of the bacterial lawn were used as indicator for toxicity. Thinning of the bacterial lawn was controlled microscopically.

CONTROLS:
- without metabolic activation:
Na-azide: TA 100, TA 1535 (1µg/plate)
9-Aminoacridine: TA 1537 (50 µg/plate)
2-Nitrofluorene: TA 98, TA 1538 (2.5 µg/plate)
N-Methyl -N-nitro-N-nitrosoguanidine (MNNG): WP2uvrA (2.5 µg/plate)

- with metabolic activation:
Benzo[a]pyrene: TA 100, TA 98, TA 1538 (0.5 µg/plate), TA 1535, TA 1537 (1 µg/plate), WP2uvrA (10 µg/plate)
* 2-Aminoanthracene: TA 98, TA 100, TA 1535, TA 1537, TA 1538, WP2uvrA (10 µg/plate)
Evaluation criteria:
Not specified
Statistics:
Not specified

Results and discussion

Test results
Species / strain:
other: Salmonella typhimurium TA98, TA100, TA1535, TA1537, TA1538
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity, but tested up to precipitating concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
Toxicity and dose range finding experiment:
The test compound was tested at doses of 4 to 10000 µg/plate and proved to be not toxic to the bacterial strains at doses of 5000 µg/plate. Visible precipitation of the test compound on the plates has been observed at 500 µg/plate. Therefore, for mutagenicity testing 5000 µg/plate was chosen as the highest dose.

Any other information on results incl. tables

Mutagenicity experiment with and without metabolic activation

Dose
(µg/plate)
TA 100 TA 1535 TA 1537 TA 1538 TA 98 WP2uvrA
  - S9 + S9 - S9 + S9 - S9 + S9 - S9 + S9 - S9 + S9 - S9 + S9
0 196 194 17 15 10 6 22 22 31 36 52 62
4 182 187 14 12 8 8 20 25 23 32 55 62
20 190 195 15 12 9 8 20 18 27 33 56 55
100 202 175 15 15 7 6 19 18 27 34 47 58
500 p 214 205 12 13 8 6 16 21 26 30 49 58
2500 p 204 212 17 16 6 7 13 22 24 31 50 66
5000 p 186 200 15 13 6 5 14 15 20 27 51 62
Positive Control 1 577 1108 377 122 120 151 490 596 375 905 183 344
Positive Control 2   1122   26   80   166   583   63

p = visible precipitation of the test compound on the plates

CONTROLS:

- positive control 1 without S9:

Sodium azide (1 µg/plate) for TA 100 and TA 1535

9 -Aminoacridine (50 µg/plate) for TA 1537

2 -Nitrofluorene (2.5 µg/plate) for TA 1538 and TA 98

MNNG (2.5 µg/plate) for WP2uvrA

- positive control 1 with S9:

2 -Aminoanthracene (0.5 µg/plate for TA 100, TA 1538 and TA 98; 1 µg/plate for TA 1535 and TA 1537; 10 µg/plate for WP2uvrA)

- positive control 2 with S9:

Benzo[a]pyrene (10 µg/plate) for all strains

Applicant's summary and conclusion

Conclusions:
Under the conditions chosen, the test substance was found to be not mutagenic in the reverse bacteria mutation assay.
Executive summary:

The test article was tested for its mutagenic potential in an Ames test performed under GLP and according to a protocol equivalent to OECD guidelines 471 and 472 in Salmonella typhimurium strains TA1535, TA100, TA1537, TA1538 and TA98 and Escherichia coli WP2 uvrA in the absence and presence of metabolic activation. In the toxicity test all strains were exposed to 4 to 10000 µg/plate and proved to be not toxic to the bacterial strains at doses up to 5000 µg/plate. A standard plate test was performed in which all test strains were exposed to 4 - 5000 µg/plate. Visible precipitation of the test compound on the plates has been observed at 500 µg/plate. The test compound did not cause a significant increase in the number of revertant colonies with any of the tester strains either in the absence or presence of metabolic activation. No dose dependent effect was obtained. Under the conditions tested, the test article is not mutagenic.